TY - BOOK
T1 - Development, Manufacture and Clinical Application of Drug Conjugates in Cancer Therapy
AU - Firer, Michael
PY - 2016/4/30
Y1 - 2016/4/30
KW - biology of drug delivery via carrier-drug conjugates
KW - overcoming cancer cell drug resistance with carrier-drug conjugates
KW - carrier alternatives—antibodies, peptides, proteins, small ligands, nanostructures
KW - technologies for discovering novel targeting agents
KW - carrier-drug conjugation chemistries
KW - manufacturing and regulatory issues of carrier-drug conjugates
KW - clinical experience with carrier-drug conjugates for cancer therapy
KW - expanding the clinical opportunities for carrier-drug conjugates
M3 - Report
SN - 2227-9059
BT - Development, Manufacture and Clinical Application of Drug Conjugates in Cancer Therapy
CY - Basel
ER -